Facilities & Utilities CQV Capabilities
Kymanox experts work with you to define your needs and customize a plan for your Facilities & Utilities Commissioning, Qualification, and Validation (CQV).
Meet our Facilities & Utilities CQV Experts
Faith Fraley
PRINCIPAL ENGINEER


Markets That Benefit from Our Facilities & Utilities CQV Solutions
Combination Products
Our experts understand the interaction between devices and drug products. Our experience includes injectables, nasal, respiratory, and more.
Biologics & Cell and Gene Therapy Services
We understand why “the product is the process” and how to implement solutions to your unique challenges.




The Kymanox Difference
At Kymanox we are more than consultants. We are partners with our clients and create custom solutions that meet each client’s unique needs.

"Right First Time” Execution
Our branded methodology, Ideal Knowledge TransferTM, combines technical project management, fundamental engineering practices, quality and regulatory expertise, and business acumen.

Proven Broad Expertise
Our diverse experience includes lyophilization cycles, cleaning and sterilization cycles, cannabis extraction, biological upstream and downstream manufacturing, medical devices and combination products.

Flexibility & Agility
At Kymanox, we make it easy for clients to get the solutions they need, when they need it. Clients tell us our flexibility is one of the key reasons they keep coming back.
Frequently Asked Facilities & Utilities CQV Questions (FAQs)
What kinds of facilities and utilities can you qualify?
Kymanox has the expertise and experience to qualify a wide range of facilities and utilities, including: cleanrooms, clean utilities, Aseptic manufacturing equipment, custom manufacturing equipment and control systems, drug product packaging equipment, controlled storage equipment and facilities, computerized software systems, building management systems (BMS), and environmental monitoring systems (EMS).
What is the purpose of CQV?
Commissioning, Qualification, and Validation (CQV) is an essential area for the life science industry. Commissioning and qualification of systems that support the drug production process (facilities, utilities, and equipment) is critical to ensure patient safety, product quality, regulatory compliance, and business needs. Our SMEs will work together with you to ensure an efficient and successful CQV process from the early stages of user requirements to operations handover. Throughout the process, Kymanox will continuously educate your team to enable knowledge transfer and ensure sustainability. Whether you are a small start-up or commercial manufacturing company, Kymanox is ready to assist you with any of facility, utility, and equipment needs.
What is commissioning and how can I be successful?
The first part of CQV is commissioning. Commissioning is defined as a documented and managed engineering approach to the start-up and turnover of facilities, systems, and equipment to end user, that results in a safe and functional environment and that meets established design requirements and stakeholder expectations. The keys to a successful commission and turnover of facilities/utilities are planning and an integrated team approach! At Kymanox, we work together with key stakeholders (system owner, quality assurance, project engineers, etc) to develop a commissioning plan, identify and execute key deliverables to ensure a seamless transition from commissioning/qualification to production.
How can I maintain the validated state of my facility/utilities?
After qualification, it is important to maintain the validated state throughout the life cycle of your equipment. There are many reasons why equipment/systems can no longer maintain a validated state (breakdowns, modifications, aging, regulatory updates, introduction of new product, etc). Therefore, the best place to start is with a strategic and comprehensive gap assessment prioritizing upgrades and replacements as needed. At Kymanox, we can assist you with a variety of solutions (performing periodic reviews, revalidation, establishing a robust change management system, etc) to ensure your facility maintains its validated state and meets regulatory compliance.
Read the Latest at Kymanox
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
Kymanox Acquires Agilis Consulting Group, A Trusted Human Factors Provider
Integrating the well-respected and trusted Agilis brand and team extends Kymanox’s capabilities in human factors (HF) by adding incredible talent, the ability to conduct HF stu...
Investment Reports Interview with Stephen M. Perry, CEO and Founder of Kymanox
Kymanox CEO and Founder, Stephen M. Perry was interviewed as part of the Investment Reports article, The New Era of Life Sciences 2023, published on 17MAR23,
What were the circumstances that brought Kymanox to life and what does your present foo...
Kymanox Acquires EU Based Anteris Medical and Anteris Helvetia
Leveraging the well-respected anteris brand and team, this acquisition extends Kymanox’s capabilities and geographic reach with a strong European presence
Friday, 03 February 2023
Morrisville, North Carolina, USA and Holzkirchen, Germany an...